UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Carvedilol as the new non‐selective beta‐blocker of choice in patients with cirrhosis and portal hypertension

Liver international, 2023-06, Vol.43 (6), p.1183-1194

2023

Volltextzugriff (PDF)

Intrahepatic vascular changes in non-alcoholic fatty liver disease: potential role of insulin-resistance and endothelial dysfunction

World journal of gastroenterology : WJG, 2017-10, Vol.23 (37), p.6777-6787

2017

Volltextzugriff (PDF)

Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement

World journal of hepatology, 2015-04, Vol.7 (4), p.688-695

2015

Volltextzugriff (PDF)

Coagulation, Microenvironment and Liver Fibrosis

Cells (Basel, Switzerland), 2018-07, Vol.7 (8), p.85

2018

Volltextzugriff (PDF)

A pragmatic strategy for the screening and treatment of portal hypertension in patients needing systemic treatment for advanced hepatocellular carcinoma

Digestive and liver disease, 2023-08, Vol.55 (8), p.997-1000

2023

Volltextzugriff (PDF)

Use of non-selective beta blockers in cirrhosis:The evidence we need before closing(or not) the window

World journal of gastroenterology : WJG, 2015-02, Vol.21 (8), p.2265-2268

2015

Volltextzugriff (PDF)

Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case–control study

JHEP reports, 2023-11, Vol.5 (11), p.100894-100894, Article 100894

2023

Volltextzugriff (PDF)

Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis

Journal of hepatology, 2020-06, Vol.72 (6), p.1140-1150

2020

Volltextzugriff (PDF)

Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report

The American journal of gastroenterology, 2020-07, Vol.115 (7), p.1140-1142

2020

Volltextzugriff (PDF)

AB0, von Willebrand factor/factor VIII and portal vein thrombosis in decompensated cirrhosis: Too late to unmask the culprit?

Liver international, 2020-07, Vol.40 (7), p.1788-1789

2020

Volltextzugriff (PDF)

A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk Stratification After Variceal Bleeding

Hepatology (Baltimore, Md.), 2020-10, Vol.72 (4), p.1353-1365

2020

Volltextzugriff (PDF)

Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis： Differences and similarities

World journal of gastroenterology : WJG, 2009-01, Vol.15 (4), p.462-466

2009

Volltextzugriff (PDF)

Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy

The American journal of gastroenterology, 2021-06, Vol.116 (6), p.1342-1344

2021

Volltextzugriff (PDF)

Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD

PloS one, 2012-04, Vol.7 (4), p.e32785-e32785

2012

Volltextzugriff (PDF)

Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort

Journal of hepatology, 2020-04, Vol.72 (4), p.702-710

2020

Volltextzugriff (PDF)

Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations

Liver international, 2018-09, Vol.38 (9), p.1624-1634

2018

Volltextzugriff (PDF)

Deep vein thrombosis in COVID-19 patients in general wards: prevalence and association with clinical and laboratory variables

Radiologia medica, 2021-05, Vol.126 (5), p.722-728

2021

Volltextzugriff (PDF)

Portal hypertension-like pattern in coronavirus disease 2019 acute respiratory distress syndrome

Journal of critical care, 2024-08, Vol.82, p.154759, Article 154759

2024

Volltextzugriff (PDF)

The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy

PloS one, 2022-07, Vol.17 (7), p.e0264106-e0264106

2022

Volltextzugriff (PDF)

Is non-alcoholic fatty liver disease a prothrombotic risk factor?

Bleeding, Thrombosis and Vascular Biology, 2023-05, Vol.2 (2)

2023

Volltextzugriff (PDF)

Improving Management of Portal Hypertension: The Potential Benefit of Non-Etiological Therapies in Cirrhosis

Journal of clinical medicine, 2023-01, Vol.12 (3), p.934

2023

Volltextzugriff (PDF)

Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences

Biomedicines, 2022-01, Vol.10 (2), p.249

2022

Volltextzugriff (PDF)

Insulin resistance and liver microcirculation in a rat model of early NAFLD

Journal of hepatology, 2011-11, Vol.55 (5), p.1095-1102

2011

Volltextzugriff (PDF)

Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus–related chronic hepatitis: Insulin resistance and response to antiviral therapy

Hepatology (Baltimore, Md.), 2007-10, Vol.46 (4), p.1009-1015

2007

Volltextzugriff (PDF)

Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity

Internal and emergency medicine, 2022-09, Vol.17 (6), p.1739-1749

2022

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(131)

Publikationsform

Sprache

Englisch
(151)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Carvedilol as the new non‐selective beta‐blocker of choice in patients with cirrhosis and portal hypertension

Intrahepatic vascular changes in non-alcoholic fatty liver disease: potential role of insulin-resistance and endothelial dysfunction

Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement

Coagulation, Microenvironment and Liver Fibrosis

A pragmatic strategy for the screening and treatment of portal hypertension in patients needing systemic treatment for advanced hepatocellular carcinoma

Use of non-selective beta blockers in cirrhosis:The evidence we need before closing(or not) the window

Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case–control study

Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis

Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report

AB0, von Willebrand factor/factor VIII and portal vein thrombosis in decompensated cirrhosis: Too late to unmask the culprit?

A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk Stratification After Variceal Bleeding

Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis： Differences and similarities

Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy

Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD

Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort

Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations

Deep vein thrombosis in COVID-19 patients in general wards: prevalence and association with clinical and laboratory variables

Portal hypertension-like pattern in coronavirus disease 2019 acute respiratory distress syndrome

The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy

Is non-alcoholic fatty liver disease a prothrombotic risk factor?

Improving Management of Portal Hypertension: The Potential Benefit of Non-Etiological Therapies in Cirrhosis

Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences

Insulin resistance and liver microcirculation in a rat model of early NAFLD

Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus–related chronic hepatitis: Insulin resistance and response to antiviral therapy

Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity

Suchergebnisse filtern